Patients with newly diagnosed malignant brain tumors are now eligible for surgically targeted radiation therapy.
GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy

Patients with newly diagnosed malignant brain tumors are now eligible for surgically targeted radiation therapy.
Velano’s PIVO device allows practitioners to collect as much blood as needed while the patient is in the hospital without additional needle sticks.
Raydiant is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth.
Raydiant Oximetry Sensing Systems is a novel, non-invasive technology that more accurately detects fetal distress during labor and delivery.
Encellin is a 2016 Rosenman Innovator and Founders Pledge company.
Early-stage health tech companies chosen for their innovative technology and high growth potential.
The proprietary DotEndo test combines information from a set of new disease biomarkers with machine learning algorithms.
The company was awarded over $3.6 million by the U.S. Army Medical Research and Material Command.
Enspectra met the lead investor for its recent Series A round last year in the Rosenman Innovators program.
The company’s technology is a minimally invasive approach toward treating anal fistula.